Glenda V. Roberts
Before going on dialysis, Glenda managed the progression of her disease using diet and exercise for 40 years. Refusing to accept limitations, she enjoyed a fulfilling career, evolving from a software developer to a senior business executive managing multi-million-dollar business units for top-caliber corporations, including Johnson & Johnson, General Electric and Microsoft. Since her transplant in 2010, she’s completed more than eight half marathons. A passionate activist for patients and kidney research, Glenda’s advocated in Washington DC, testifying before the House Congressional Kidney Caucus in support of the Kidney Precision Medicine Project (KPMP); petitioning Washington’s Congressional delegation to support NIDDK/NIH funding, ESRD Medicare budget protection, apt quality metrics for in-center, bedridden dialysis patients, and expanding transplant recipients immunosuppression drug benefits; and participating on Capitol Hill Days to secure support for Congressional legislation that impacts people with kidney disease. Currently, she serves on the Community Advisory Board for the APOL1 Study, the KPMP Community Engagement Committee, the NIDDK APOLLO Community Advisory Board, the Kidney Health Initiative Vascular Access Patient Reported Outcomes Working Group and the UWMC Team Transplant Recruitment Committee.